Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
US1280583022
Tue, 21.01.2025
Lisata Therapeutics Inc
Company Name:
Lisata Therapeutics Inc
ISIN:
US1280583022
Reason for the research:
Initiation of coverage
Recommendation:
BUY
from:
21.01.2025
Target price:
USD15.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research on 21/01/2025 initiated coverage on Lisata Therap [ … ]